M&R Capital Management Inc. cut its position in Colgate-Palmolive (NYSE:CL) by 43.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 41,576 shares of the company’s stock after selling 31,400 shares during the period. M&R Capital Management Inc.’s holdings in Colgate-Palmolive were worth $2,963,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CL. Transamerica Financial Advisors Inc. increased its position in shares of Colgate-Palmolive by 0.3% during the first quarter. Transamerica Financial Advisors Inc. now owns 25,183 shares of the company’s stock worth $1,844,000 after acquiring an additional 67 shares in the last quarter. Ronald Blue & Co. LLC increased its position in shares of Colgate-Palmolive by 1.1% during the first quarter. Ronald Blue & Co. LLC now owns 3,501 shares of the company’s stock worth $256,000 after acquiring an additional 37 shares in the last quarter. USS Investment Management Ltd increased its position in shares of Colgate-Palmolive by 1.6% during the first quarter. USS Investment Management Ltd now owns 683,600 shares of the company’s stock worth $50,036,000 after acquiring an additional 10,600 shares in the last quarter. Stifel Financial Corp increased its position in shares of Colgate-Palmolive by 0.8% during the first quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock worth $22,250,000 after acquiring an additional 2,360 shares in the last quarter. Finally, ARS Investment Partners LLC increased its position in shares of Colgate-Palmolive by 0.5% during the first quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock worth $2,601,000 after acquiring an additional 175 shares in the last quarter. Institutional investors own 72.96% of the company’s stock.
Shares of Colgate-Palmolive (NYSE CL) traded down $0.34 during mid-day trading on Thursday, reaching $74.25. 2,698,300 shares of the company’s stock were exchanged, compared to its average volume of 3,606,011. The firm has a market capitalization of $65,497.87, a PE ratio of 25.99, a P/E/G ratio of 3.42 and a beta of 0.81. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting analysts’ consensus estimates of $0.73. The firm had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 earnings per share. research analysts expect that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date of this dividend was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.
CL has been the subject of several research reports. Citigroup lowered their price objective on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research report on Thursday, November 2nd. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Monday, October 23rd. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their target price for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. Finally, Jefferies Group reaffirmed a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Two equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $76.04.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, COO Justin Skala sold 126,393 shares of the stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the completion of the sale, the chief operating officer now owns 262,361 shares of the company’s stock, valued at approximately $19,144,482.17. The disclosure for this sale can be found here. In the last quarter, insiders sold 173,673 shares of company stock valued at $12,629,293. Corporate insiders own 1.02% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “M&R Capital Management Inc. Has $2.96 Million Holdings in Colgate-Palmolive (CL)” was originally published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.thelincolnianonline.com/2017/12/07/mr-capital-management-inc-has-2-96-million-holdings-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.